A Novel Small-Molecule Inhibitor of Transforming Growth Factor Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth in Vivo and Prevents Tumor Recurrence After Surgical Resection

Cancer Research - United States
doi 10.1158/0008-5472.can-06-2389
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-Β Type I Receptor Kinase Inhibitor

Cancer Research
Cancer ResearchOncology
2006English

Dihydropyrrolopyrazole Transforming Growth Factor-B Type I Receptor Kinase Domain Inhibitors: A Novel Benzimidazole Series With Selectivity Versus Transforming Growth Factor-B Type II Receptor Kinase and Mixed Lineage Kinase-7

English

Hematein, a Casein Kinase II Inhibitor, Inhibits Lung Cancer Tumor Growth in a Murine Xenograft Model

International Journal of Oncology
Cancer ResearchOncology
2013English

Small-Molecule P21-Activated Kinase Inhibitor PF-3758309 Is a Potent Inhibitor of Oncogenic Signaling and Tumor Growth

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor and Activin-A

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Regulation of Murine Type 1 Plasminogen Activator Inhibitor Gene Expression in Vivo. Tissue Specificity and Induction by Lipopolysaccharide, Tumor Necrosis Factor-Alpha, and Transforming Growth Factor-Beta.

Journal of Clinical Investigation
Medicine
1991English

Type I Transforming Growth Factor Β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

PCC0208027, a Novel Tyrosine Kinase Inhibitor, Inhibits Tumor Growth of NSCLC by Targeting EGFR and HER2 Aberrations

Scientific Reports
Multidisciplinary
2019English

Soluble Tumor Necrosis Factor Receptor Type I Enhances Tumor Development and Persistence in Vivo

Cellular Immunology
Immunology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy